Joseph Vittiglio
CIK 1551776 · Chief Business & Legal Officer · last filed 2026-03-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$158.4K
Companies
5
Total Filings
36
Lifetime Open-Market Net
-$83.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PEPG | Chief Business & Legal Officer | 65,717 | $2.41 | $158.4K | $0 | 2 | 2026-03-02 |
| bluebird bio, Inc. (BLUE) Delisted | Chief Business & Legal Officer | 3,125 | $4.97 | $15.5K | -$6.5K | 6 | 2025-06-03 |
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Chief Business & Legal Officer | 1,045 | $7.30 | $7.6K | -$5.1K | 4 | 2022-10-25 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Chief Business Officer, GC | 0 | — | — | -$56.9K | 17 | 2020-11-17 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | SVP, General Counsel | 2,092 | $15.00 | $31.4K | -$15.5K | 5 | 2015-01-08 |
Recent Filings · Page 2 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-15 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2022-02-28 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-21 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-18 | — | Grant (A) | — | $0 | |
| 2020-11-17 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Disp (D) | −92,244 | $0 | EDGAR |
| 2020-03-12 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2020-03-04 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −1,138 | -$8.8K | EDGAR |
| 2020-02-25 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −3,073 | -$27.7K | EDGAR |
| 2019-03-11 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Sell (S) | −1,425 | -$20.0K | EDGAR |
| 2019-03-05 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −2,132 | -$31.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.